Recro Gainesville Drug Patent Portfolio

Recro Gainesville owns 1 orange book drug protected by 18 US patents Given below is the list of Recro Gainesville's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10092559 Abuse resistant pharmaceutical compositions 12 Sep, 2034
Active
US9132096 Abuse resistant pharmaceutical compositions 12 Sep, 2034
Active
US9452163 Abuse resistant pharmaceutical compositions 12 Sep, 2034
Active
US9486451 Abuse resistant pharmaceutical compositions 12 Sep, 2034
Active
US9713611 Abuse resistant pharmaceutical compositions 12 Sep, 2034
Active
US10028946 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US10322120 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US10456393 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US10722511 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US9265760 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US9326982 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US9333201 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US9339499 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US9421200 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US9433619 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US9610286 Treating pain in patients with hepatic impairment 25 Jul, 2033
Active
US6228398 Multiparticulate modified release composition 01 Nov, 2019 Expired
US6902742 Multiparticulate modified release composition 01 Nov, 2019 Expired


Given below is the list of recent legal activities going on the following drug patents of Recro Gainesville.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 01 Jul, 2024 US9486451
Maintenance Fee Reminder Mailed 20 May, 2024 US9452163
Maintenance Fee Reminder Mailed 29 Apr, 2024 US9433619
Maintenance Fee Reminder Mailed 15 Apr, 2024 US9421200
Maintenance Fee Reminder Mailed 18 Mar, 2024 US10722511
Expire Patent 04 Dec, 2023 US10456393
Expire Patent 24 Jul, 2023 US10322120
Maintenance Fee Reminder Mailed 19 Jun, 2023 US10456393
Payment of Maintenance Fee, 8th Year, Large Entity 15 Mar, 2023 US9132096 (Litigated)
Maintenance Fee Reminder Mailed 06 Feb, 2023 US10322120
Expire Patent 29 Aug, 2022 US10028946
Payment of Maintenance Fee, 4th Year, Large Entity 20 Apr, 2022 US10092559
Surcharge for Late Payment, Large Entity 20 Apr, 2022 US10092559
Maintenance Fee Reminder Mailed 14 Mar, 2022 US10028946
Payment of Maintenance Fee, 4th Year, Large Entity 25 Jan, 2021 US9713611


Recro Gainesville's Family Patents

Recro Gainesville drugs have patent protection in a total of 22 countries. It's US patent count contributes only to 47.2% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Recro Gainesville Drug List

Given below is the complete list of Recro Gainesville's drugs and the patents protecting them.


1. Zohydro Er

Zohydro Er is protected by 18 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10092559 Abuse resistant pharmaceutical compositions 12 Sep, 2034
(9 years from now)
Active
US9132096 Abuse resistant pharmaceutical compositions 12 Sep, 2034
(9 years from now)
Active
US9452163 Abuse resistant pharmaceutical compositions 12 Sep, 2034
(9 years from now)
Active
US9486451 Abuse resistant pharmaceutical compositions 12 Sep, 2034
(9 years from now)
Active
US9713611 Abuse resistant pharmaceutical compositions 12 Sep, 2034
(9 years from now)
Active
US10028946 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US10322120 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US10456393 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US10722511 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US9265760 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US9326982 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US9333201 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US9339499 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US9421200 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US9433619 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US9610286 Treating pain in patients with hepatic impairment 25 Jul, 2033
(8 years from now)
Active
US6228398 Multiparticulate modified release composition 01 Nov, 2019
(5 years ago)
Expired
US6902742 Multiparticulate modified release composition 01 Nov, 2019
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zohydro Er's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List